PortfoliosLab logoPortfoliosLab logo
ISRG vs. JNJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ISRG vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intuitive Surgical, Inc. (ISRG) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ISRG achieves a -27.42% return, which is significantly lower than JNJ's 17.68% return. Over the past 10 years, ISRG has outperformed JNJ with an annualized return of 19.09%, while JNJ has yielded a comparatively lower 10.46% annualized return.


ISRG

1D
-0.45%
1M
-3.97%
YTD
-27.42%
6M
-24.20%
1Y
-19.74%
3Y*
9.23%
5Y*
7.37%
10Y*
19.09%

JNJ

1D
1.07%
1M
4.96%
YTD
17.68%
6M
15.11%
1Y
57.15%
3Y*
17.82%
5Y*
10.94%
10Y*
10.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ISRG vs. JNJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ISRG
Intuitive Surgical, Inc.
-27.42%8.51%54.72%27.14%-26.15%31.76%38.39%23.43%31.23%72.64%
JNJ
Johnson & Johnson
17.68%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%

Correlation

The correlation between ISRG and JNJ is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.04

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2000

0.25

The correlation between ISRG and JNJ shifts across timeframes, from 0.04 (3 years) to 0.26 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ISRG:

$147.90B

JNJ:

$588.98B

EPS

ISRG:

$8.24

JNJ:

$8.65

PE Ratio

ISRG:

49.88

JNJ:

27.85

PEG Ratio

ISRG:

3.05

JNJ:

0.93

PS Ratio

ISRG:

14.04

JNJ:

6.08

PB Ratio

ISRG:

8.40

JNJ:

7.25

Total Revenue (TTM)

ISRG:

$10.58B

JNJ:

$96.36B

Gross Profit (TTM)

ISRG:

$7.02B

JNJ:

$66.60B

EBITDA (TTM)

ISRG:

$3.76B

JNJ:

$31.62B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ISRG vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ISRG
ISRG Risk / Return Rank: 1616
Overall Rank
ISRG Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
ISRG Sortino Ratio Rank: 1414
Sortino Ratio Rank
ISRG Omega Ratio Rank: 1616
Omega Ratio Rank
ISRG Calmar Ratio Rank: 2020
Calmar Ratio Rank
ISRG Martin Ratio Rank: 1414
Martin Ratio Rank

JNJ
JNJ Risk / Return Rank: 9696
Overall Rank
JNJ Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9797
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9393
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ISRG vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intuitive Surgical, Inc. (ISRG) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ISRGJNJDifference
Sharpe ratioReturn per unit of total volatility

-4.07

Sortino ratioReturn per unit of downside risk

-5.81

Omega ratioGain probability vs. loss probability

0.90

1.61

-0.71

Calmar ratioReturn relative to maximum drawdown

-0.62

5.28

-5.90

Martin ratioReturn relative to average drawdown

-1.24

15.52

-16.77

ISRG vs. JNJ - Sharpe Ratio Comparison

The current ISRG Sharpe Ratio is -0.65, which is lower than the JNJ Sharpe Ratio of 3.42. The chart below compares the historical Sharpe Ratios of ISRG and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ISRG vs. JNJ - Drawdown Comparison

The maximum ISRG drawdown since its inception was -82.26%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for ISRG and JNJ.


Loading charts...

Drawdown Indicators


ISRGJNJDifference

Max Drawdown

Largest peak-to-trough decline

-82.26%

-50.67%

-31.59%

Max Drawdown (1Y)

Largest decline over 1 year

-32.14%

-10.96%

-21.18%

Max Drawdown (3Y)

Largest decline over 3 years

-34.10%

-15.95%

-18.15%

Max Drawdown (5Y)

Largest decline over 5 years

-49.90%

-18.41%

-31.49%

Max Drawdown (10Y)

Largest decline over 10 years

-49.90%

-27.37%

-22.53%

Current Drawdown

Current decline from peak

-32.66%

-2.54%

-30.12%

Average Drawdown

Average peak-to-trough decline

-21.28%

-11.90%

-9.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.00%

3.72%

+12.28%

Volatility

ISRG vs. JNJ - Volatility Comparison

Intuitive Surgical, Inc. (ISRG) has a higher volatility of 9.70% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that ISRG's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ISRGJNJDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.70%

5.47%

+4.23%

Volatility (6M)

Calculated over the trailing 6-month period

20.72%

12.16%

+8.56%

Volatility (1Y)

Calculated over the trailing 1-year period

30.69%

16.94%

+13.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.19%

16.87%

+16.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.40%

18.48%

+13.92%

Dividends

ISRG vs. JNJ - Dividend Comparison

ISRG has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.18%.


PositionTTM20252024202320222021202020192018201720162015
ISRG
Intuitive Surgical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
JNJ
Johnson & Johnson
2.18%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%

Financials

ISRG vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Intuitive Surgical, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20222023202420252026
2.77B
24.06B
(ISRG) Total Revenue
(JNJ) Total Revenue
Values in USD except per share items

ISRG vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Intuitive Surgical, Inc. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

65.0%66.0%67.0%68.0%69.0%70.0%71.0%20222023202420252026
66.1%
71.5%
Portfolio components
ISRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a gross profit of 1.83B and revenue of 2.77B. Therefore, the gross margin over that period was 66.1%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

ISRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported an operating income of 855.30M and revenue of 2.77B, resulting in an operating margin of 30.9%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

ISRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intuitive Surgical, Inc. reported a net income of 821.50M and revenue of 2.77B, resulting in a net margin of 29.7%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.


Frequently Asked Questions


ISRG and JNJ have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ISRG has higher volatility (9.70%) compared to JNJ (5.47%). In terms of maximum drawdown, ISRG dropped -82.26% vs JNJ's -50.67%.

JNJ currently has the higher Sharpe Ratio (3.42 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ISRG and JNJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer